Table 6.
Predictive value of psoas muscle parameters combined with age for long-term mortality in a meta-analysis of three different patient population in women.
| AUC value for Long-term Mortality |
|||
|---|---|---|---|
| Fixed effects | Random effects | I2 | |
| L3 Level measurement | |||
| PMA | 0.595(0.551–0.640) | 0.595(0.551–0.640) | 0 |
| PMD | 0.601(0.556–0.646) | 0.609(0.546–0.672) | 0.25 |
| PMA/height | 0.595(0.551–0.639) | 0.595(0.551–0.639) | 0 |
| PMA/BSA | 0.587(0.542–0.631) | 0.587(0.542–0.631) | 0 |
| sLPMA | 0.590(0.545–0.634) | 0.590(0.545–0.634) | 0 |
| pLPMA | 0.583(0.538–0.628) | 0.583(0.538–0.628) | 0 |
| L4 level measurement | |||
| PMA | 0.598(0.554–0.642) | 0.598(0.554–0.642) | 0 |
| PMD | 0.604(0.560–0.649) | 0.615(0.550–0.679) | 0 |
| PMA/height | 0.599(0.555-0.643) | 0.599(0.555–0.643) | 0 |
| PMA/BSA | 0.589(0.544–0.634) | 0.589(0.544–0.634) | 0 |
| sLPMA | 0.593(0.548–0.637) | 0.593(0.548–0.637) | 0 |
| pLPMA | 0.591(0.546–0.636) | 0.591(0.546–0.636) | 0 |
Abbreviations: PMA: Psoas muscle area; PMD: Psoas muscle density; BSA: body-surface area; sLPMA: sum score of lean psoas muscle mass; pLPMA: Product score of Lean Psoas.